As discussed in this work, many studies show the beneficial effect of GluN1 blockade on epilepsy, either by pharmacological antagonists or by genetic manipulation (transgenic approaches, knockout, or use of RNAi) [21,22,23]. Here, GRIN1 is linked to epilepsy.